The levels of active ADAM10 in platelets were demonstrated to be decreased in AD patients, compared to the levels of cognitively healthy controls [15–19], whereas the levels of inactive and soluble ADAM10 in plasma were increased in MCI and AD [12]. The gene discussed is ADAM10; the disease is Alzheimer disease.